AbbVie Contract Manufacturing的动态

Dear Esteemed Colleagues in the Pharmaceutical Industry, I trust this message finds you in good health and high spirits. I would like to convey my sincere best wishes to all esteemed peers who will be in attendance at CPhI Worldwide 2024 in Milan. The anticipation for the upcoming CPhI is palpable. I hope your participation in the event will yield fruitful outcomes, leading to the establishment of prosperous business partnerships for collective advancement. Given the limited timeframe of approximately 2.5 days for the event, it is imperative to thoughtfully arrange pre-scheduled meetings. Unfortunately, time constraints may restrict in-depth dialogues and the ability to meet all intended business associates. Nonetheless, we can leverage virtual platforms such as LinkedIn, telephone calls, WhatsApp, and Teams to engage in comprehensive discussions and interactions, transcending the constraints of physical meetings for those with whom an in-person meeting may not be feasible. While time is of the essence, it is crucial to nurture mutual understanding and cultivate robust professional relationships, recognizing each individual's pivotal role in the pharmaceutical landscape. I extend my sincere wishes for the success of all my colleagues at the upcoming CPhI 2024 event in Milan. Warm regards,

Want to learn more about hot topics for pharmaceuticals regarding market access & public procurement? Join us at our upcoming PharmaAccess event in Paris! Register here: https://lnkd.in/ebcy8pSF hashtag #marketaccess hashtag #pharmaceuticals hashtag #publicprocurement

Excited for the Pharma CI Conference in Newark! I’ll be representing SI Insights at this year’s Pharma CI conference and am looking forward to connecting with fellow professionals. Here’s what you can expect from us: ?? Comprehensive Coverage of the Indian, African, and Southeast Asian pharma markets for your consulting and competitive intelligence (CI) needs. ?? Expertise in US and EU pharma markets for tailored CI projects. Whether you're looking for insights, collaboration, or new opportunities, I’d love to meet and discuss how SI Insights can support your pharma CI and consulting goals. Let’s connect! ?? #PharmaCI #PharmaConsulting #CompetitiveIntelligence #SIInsights #PharmaMarkets #IndiaPharma #AfricanPharma #SoutheastAsiaPharma #USPharma #EUPharma #PharmaExpertise

How can we strengthen the ROI of incorporating digital biomarkers in drug development trials and accelerate its adoption… looking forward to hearing the sessions today and sharing the insights! #DigitalBiomarkersSummit #medidata #clinicalinnovation

Please join me and many other Medical Affairs experts at the 16th annual #MedAffairs #Transformation conference on November 14 in Zurich, Switzerland. I'll share my perspectives on 'the impact of medical affairs on the corporate's mid and long-term strategy' and join a panel session to discuss 'the Impact of internal and external stakeholder value needs on Medical Affairs capabilities development' Please learn more about the program and find out how to register below. Looking forward to engaging discussions and catching up with friends! #ViaViatris #EvidenceLifeScience

?? Exciting News: I’ll be attending CPHI this year, representing both 1MED and 1LAB! As the Head of Preclinical BU at 1MED SA and R&D and BD Manager at 1LAB SA, I’m thrilled to share that this will be a great opportunity to introduce our newest venture: 1LAB. ?? 1LAB is a research and development laboratory within the 1MED group, positioned as a strategic and consultative partner, especially for start-ups and companies in the medtech, cosmetic, and nutraceutical sectors. What sets us apart? Our operational agility and ability to offer personalized services that go beyond simple test execution. At 1LAB, we focus on problem-solving, regulatory compliance, and product certification—bringing the benefit of a deep partnership with 1MED, which ensures we understand the next steps in your journey to market success. We offer a blend of university-like innovation with a commitment to quality and efficiency, making us an ideal partner for start-ups and companies seeking tailored solutions. With my background in pharmaceutical technology and regulatory affairs, I’m confident our team can deliver a comprehensive range of services—from R&D and product development, to validation, efficacy, and safety testing, right through to regulatory support. I’d love to connect during CPHI! Let’s schedule a meeting to explore how 1LAB can support your projects and drive your success. #MedTech #CPHI #1LAB #Innovation #R&D #Pharma #Startups #1MED #Nutraceuticals

Drop by 4 A01 to discover how our CDMO team can help in your faster market access. Sun Pharma Expertise across pharma value chain #Sunpharma# #CDMO# #CRAMS# #SUNExpertise#

#EMA’s Annual Report 2023 is out. ???? The European Medicines Agency (EMA) has released its 2023 Annual Report, providing a comprehensive look at their work throughout the year. This edition boasts a fresh design and interactive features, making it an engaging resource for anyone interested in the world of pharmaceutical / medical regulation and public health. The report delves into EMA's strategic priorities, highlighting their efforts in three areas: ? Combating Cancer: Discover how EMA is accelerating access to innovative cancer medicines through initiatives like the 'Cancer Medicines Pathfinder.’ ? Embracing the Data Revolution: Explore EMA's approach to data-driven medicine regulation, ensuring robust scientific evaluation while fostering innovation. ? Transparency and Open Communication: Learn how EMA prioritizes clear communication with healthcare professionals and the public. The report goes beyond summaries, offering a selection of key figures and trends that illustrate the broader impact of EMA's work and its influence on European public health. The EMA provides the report in two formats to cater to different preferences. Explore the interactive report for more details ?? https://lnkd.in/ddCNMkxX Do you need help understanding the European medical device ecosystem and its potential implication on your business? We guide you with hands-on support through the jungle of requirements. Reach out to us ??[email protected] #EMAAnnualReport2023 #PublicHealth #EUHealthcare #MedicalAdvancements #medtech #regulatoryaffairs #clinicalstudies #MDR #IVDR #medicaldevices #Europe #healthcare #technology #science

Unveiling the Potential: The Attractiveness of R&D in the Netherlands Today I had the pleasure to participate in a panel discussion about "Research & Development: How Attractive is the Netherlands?" organized by Axon Healthcare and hosted by J&J Innovative Medicine Nederland. This meeting brought together over 180 participants from the healthcare and pharmaceutical sectors, both in-person and online, to delve into the opportunities and challenges within the Dutch R&D landscape. The event was kicked off by Michel van Agthoven, who emphasized the Netherlands' commitment to fostering an innovative ecosystem for drug development. Speakers such as Wiesje van der Flier and Jos GW Kosterink highlighted the Dutch academic excellence, the synergy between academic institutions and industry, underscoring the pivotal role of this collaboration in maintaining the Netherlands' position at the forefront of pharmaceutical innovation. Discussions centered on several compelling statements, facilitated by Hans Schikan of Health~Holland, including the enhancement of clinical development through better understanding of multinational study complexities and the critical nature of quality data delivery. The dialogue extended to potential risks, such as the impact of focusing solely on cost reduction which could lead to a decline in local R&D activities. Notable contributions came from Annemiek Verkamman and Benien Vingerhoed - van Aken, who discussed the strategic importance of clear regulatory frameworks but also partnerships between universities, hospitals, and the industry to secure the Netherlands as a leader in patient access to innovative treatments. The collective panel insights showed a robust infrastructure well-suited to the rapid advancements in medicine, making the Netherlands a prime location for international studies. Looking forward, it is clear that the Netherlands is set to not only continue but to enhance its role in the global R&D arena. With the Dutch Clinical Research Foundation soon to be launched National Actionplan Clinical Research we look forward to accelerating the next steps. Thank you to all the participants and speakers who made this event so full of insights and ideas. Look foreatd to continue to engage and expand the network to further the advancements in sustainable healthcare. Your thoughts and participation in upcoming discussions are highly valued as well so please engage! #clinicalresearch #healthcareinnovation #sustainablehealthcare #clinicaltrials

? Namaste Global Heads to CPHI North America: Bridging the Gap for Indian Healthcare in the US Market! ? We as Namaste Global will be attending CPHI North America, the premier pharmaceutical event, happening 07 – 09 May in Philadelphia! Our founder, ?? Sanchit Sharma, and our team of ?? scientific experts are eager to connect with industry leaders, explore the latest advancements in biopharma, and showcase how Namaste Global empowers Indian healthcare companies to seamlessly enter and thrive in the US market. Are you an Indian CDMO looking to expand your reach? CPHI provides the perfect platform to connect with potential US partners and unlock new growth opportunities. We understand the challenges CDMOs face in navigating the US market, and our team is here to help! At CPHI, we'll be discussing: ? Strategies for Indian CDMOs to successfully enter the US market. ? Building strategic partnerships with US pharmaceutical companies. ? Leveraging Namaste Global's expertise to overcome regulatory hurdles and cultural differences. Connect with us! We'd love to discuss your specific needs and how Namaste Global can help you achieve your US expansion goals. Schedule your meet with us between May 7 – 9 by writing to us at [email protected] or comment below. #CPHI #NorthAmerica #Pharma #CDMO #India #USA #Healthcare #MarketEntry #Partnerships